A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

OBJECTIVE The purpose of this study is to explore the diagnostic performance of two investigational quantitative ultrasound (QUS) parameters, attenuation coefficient and backscatter coefficient, in comparison with conventional ultrasound (CUS) and MRI-estimated proton density fat fraction (PDFF) for predicting histology-confirmed steatosis grade in adults with nonalcoholic fatty liver disease (NAFLD). SUBJECTS AND METHODS In this prospectively designed pilot study, 61 adults with histology-confirmed NAFLD were enrolled from September 2012 to February 2014. Subjects underwent QUS, CUS, and MRI examinations within 100 days of clinical-care liver biopsy. QUS parameters (attenuation coefficient and backscatter coefficient) were estimated using a reference phantom technique by two analysts independently. Three-point ordinal CUS scores intended to predict steatosis grade (1, 2, or 3) were generated independently by two radiologists on the basis of QUS features. PDFF was estimated using an advanced chemical shift-based MRI technique. Using histologic examination as the reference standard, ROC analysis was performed. Optimal attenuation coefficient, backscatter coefficient, and PDFF cutoff thresholds were identified, and the accuracy of attenuation coefficient, backscatter coefficient, PDFF, and CUS to predict steatosis grade was determined. Interobserver agreement for attenuation coefficient, backscatter coefficient, and CUS was analyzed. RESULTS CUS had 51.7% grading accuracy. The raw and cross-validated steatosis grading accuracies were 61.7% and 55.0%, respectively, for attenuation coefficient, 68.3% and 68.3% for backscatter coefficient, and 76.7% and 71.3% for MRI-estimated PDFF. Interobserver agreements were 53.3% for CUS (κ = 0.61), 90.0% for attenuation coefficient (κ = 0.87), and 71.7% for backscatter coefficient (κ = 0.82) (p < 0.0001 for all). CONCLUSION Preliminary observations suggest that QUS parameters may be more accurate and provide higher interobserver agreement than CUS for predicting hepatic steatosis grade in patients with NAFLD.

[1]  T. Riley,et al.  Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[2]  Q. Pan,et al.  Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[3]  Arun J. Sanyal,et al.  非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨 , 2015 .

[4]  S. Ahn,et al.  Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[5]  A. Gamst,et al.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.

[6]  A. Gamst,et al.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.

[7]  P. Hayes,et al.  The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. , 2011, Clinical radiology.

[8]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[9]  Nik Raihan Nik Mustapha,et al.  Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Journal of gastroenterology and hepatology.

[10]  L Dalla Palma,et al.  Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.

[11]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[12]  Anthony Gamst,et al.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[14]  L. X. Yao,et al.  Backscatter Coefficient Measurements Using a Reference Phantom to Extract Depth-Dependent Instrumentation Factors , 1990, Ultrasonic imaging.

[15]  A. Lonardo,et al.  Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[16]  H. Ermert,et al.  An ultrasound research interface for a clinical system , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[17]  J. Stoker,et al.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.

[18]  S. Mudaliar,et al.  Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes , 2011, Diabetes, obesity & metabolism.

[19]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[20]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[21]  M. Kumar,et al.  Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance? , 2013, Journal of gastroenterology and hepatology.

[22]  C. Sirlin,et al.  In vivo characterization of the liver fat 1H MR spectrum , 2011, NMR in biomedicine.

[23]  B. Choi,et al.  Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images--initial experience. , 2005, Radiology.

[24]  L. Katsnelson,et al.  Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.

[25]  A. McCullough,et al.  Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. , 2009, Journal of hepatology.

[26]  S. Horgan,et al.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.